Join
Live feed
·
PRReleasevia Quantisnow
Kineta Inc. logo

Kineta Reopens Enrollment for the VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

ByQuantisnow·Wall Street's wire, on your screen.
KA· Kineta Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KA (Kineta Inc.) and more on Quantisnow.